AxisWire Archives - Green Market Report

AxisWireAxisWireJune 14, 2019
Screen-Shot-2019-06-14-at-10.10.24-AM.png

4min1110

Event offers conversations with California’s cannabis leadership, updates on important new regulations, and celebrates the launch of the California Bureau of Cannabis Control’s powerful new ad campaign

Los Angeles, CA – June 14, 2019 /AxisWire/ The United Cannabis Business Association (UCBA), the premier trade association for legal retail cannabis in California, announces its second annual Policy Summit, presented by Linx. The one-day event is on June 21, at the Montalban Theater in Los Angeles.

The Summit provides access to key decision makers and industry leaders in a unique environment to give cannabis professionals insight on changing regulations and market conditions that will significantly impact their businesses. The one-of-a-kind event will conclude with a sun-filled rooftop VIP mixer featuring a Sessions short order kitchen by Chef Holden Jagger of Altered Plates, live music and entertainment.

The Summer Summit will also serve as the launch of the Bureau of Cannabis Control’s California new public awareness and education campaign, designed to help businesses and consumers recognize the differences between legal and illicit cannabis products and retailers.

The summit will feature candid discussions on issues that impact California cannabis businesses and consumers, with notable speakers that include:

Nicole Elliott – Senior Advisor on Cannabis to Governor Newsom Lori Ajax – Chief of the CA Bureau of Cannabis Control Cat Packer – Executive Director and GM of the LA Department of Cannabis Regulation Fiona Ma – CA State Treasurer Councilmember Herb Wesson – Los Angeles City Council President Senator Steven Bradford, CA Senate District 35 Assemblyman Tom Lackey, CA Assembly District 36 Richard Parrott – CalCannabis Cultivation Licensing, CA Department of Food and Agriculture Rasha Salama – Branch Chief, CA Manufactured Cannabis Safety Branch Laurie Holcomb – CEO of Gold Flora Farms and King’s Crew Dispensary

The UCBA Summer Summit is presented in collaboration with the Humboldt County Growers Alliance (HCGA) – the trade association representing the most legal cultivation businesses in California, and brings together two of the most influential cannabis industry associations in the state.

Attendees to the Summit will enjoy Linx giveaways, specials with neighboring dispensaries, a rooftop lounge, and a brand education mezzanine with executives from some of the most successful businesses in the industry, including Gold Flora, Original Pot Company, Canndescent, Beboe, Cresco, Born from Flora, Genius, Delta 9, 1 PUFF, Kanha Treats, LA Kush, Boxcar Supply Company and more.

The Second Annual UCBA Policy Summit and BBQ is on June 21, 11a-6p, at the Montalban Theater, 1615 Vine Street, Hollywood, CA 90028. For tickets, visit: bit.ly/UCBA2019Summit

Veterans and Social Equity applicants receive free admission.

For information on UCBA, visit: www.ucba.com

Connect:

Website: www.ucba.com

Facebook: facebook.com/UCBATradeAssociation

Instagram: instagram.com/ucbanetwork

LinkedIn: linkedin.com/company/ucba

Media: hello@inov8.us


AxisWireAxisWireJune 4, 2019
img_ezgreen.jpg

9min560

ezGreen’s Point-of-Sale solutions now sanctioned by Metrc Cannabis Control Commissions in Six States

Fort Lauderdale, FL.– June 4, 2019 /AxisWire/ The ezGreen Compliance team has 17 years of experience in medical dispensing of pharmaceuticals to medical clinics across the United States.  This first-hand knowledge of heavily regulated health industries and HIPAA compliance is an essential element to developing a comprehensive software platform for the nascent cannabis industry – the fastest growing industry in the United States –one that is expected to reach $17 billion worldwide in 2019.

In the last two years, ezGreen Compliance (“ezGreen”) has developed a software system with multiple features, many of which have been missing from other industry platforms due to data breaches and shutdowns.  Creators of the ezGreen platform have just announced the completed integration with Marijuana Tracking Reporting Enforcement Compliance (“Metrc”) for six states-California, Colorado, Maryland, Massachusetts, Montana, and Oregon. Mandatory for all cannabis-legal states, compliance software is an important choice for cannabis businesses.

Currently, the number of those in the legal cannabis industry participating in a “track-and-trace” computer system is low, reasons cited include bureaucracy and timing. Michael R Blood of the Associated Pressreported that as of April 2019, just nine California retail outlets were entering data into the network established under an estimated $60 million state contract, even though 627 shops are licensed to sell pot in California.

Tracking products in real time, ezGreen is able to monitor the movements of products within the dispensary retail location to ensure they are reporting up to date inventory to the State through the Metrc portal.  ezGreen’s Point-of-Sale software eliminates the need for manual data entry when reporting information to Metrc. As retailers or dispensaries accept inbound product information on their Metrc portal, ezGreen receives chain of custody for all products delivered from the distributor to the retail dispensary, automatically batching and labeling every product prior to sale. The platform also integrates the Health Insurance Portability and Accountability Act (HIPAA) certified POS solution developed and supported by Automated HealthCare Solutions (AHCS). AHCS is a leading point-of-care tracking and dispensing software solution developed over the past 17 years which has supported over 3500 active physician operated clinics and dispensaries, all while maintaining HIPAA compliance following essential Health and Human Services standards in the United States.

To remain compliant, licensees must migrate their current inventory to the platform, enabling the tracking and reporting of cannabis and cannabis-related products as they move through the commercial supply chain.  ezGreen’s POS software supports and simplifies the maintenance and security of accurate reporting, inventory tracking, as well as product trends, and purchase amounts–which in some states are restricted.  The ezGreen Compliance platform also tracks taxes and regulations, keeping licensees up to date on changes at the local, state and national levels.

“Cannabis industry data standards are increasingly mirroring the pharmaceutical industry’s patient data security protocols,” said Mike Coner, President of ezGreen. “We are on top of that and more. Our POS solution delivers data security and integrates with any seed to sale technology platform.  ezGreen also provides fully customized reporting and real-time data analytics enabling businesses to make more effective decisions for their customers. In addition to our recent integration with Metrc, we are now able to provide patient and customer data protection within a state-approved end to end solution.”

About Metrc

Metrc was created by Franwell, a leading technology company dedicated to the development of leading products and services focused on supply chain solutions and RFID integration for the Agriculture industry.  First deployed for the Cannabis industry in 2013, Metrc is a web-based solution made up of a browser interface and a mobile application for both the industry and regulatory users that provides end to end tracking and tracing of marijuana plants and products.  The backend is a series of secure Web Services, Database and an Application Programming Interface (API). This solution was specifically designed for government agencies in charge of legalized marijuana enforcement. Metrc provides the necessary visibility for adherence to rules, regulations, and statutes. Currently, Metrc is contracted by the following states, Alaska, California, Colorado, Oregon, Maryland, Michigan, Ohio, Massachusetts, Montana, Nevada, Louisiana, and Washington D.C. For additional information visit https://www.metrc.com.

About ezGreen Compliance

ezGreen Compliance, located in Fort Lauderdale FL, is a proven state-of-the-art software enterprise compliance and Point-of-Sale software solution for licensed medical cannabis dispensaries and recreational retailers. Navigating through state-by-state license, tax and compliance issues has been challenging for the legal cannabis industry.  ezGreen Compliance helps customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”)and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations while providing operators with a seamless and comprehensive software solution for compliance and their customer base.   For more information on this innovative software company please visit www.ezgreencompliance.com.

CONTACT:

Gaynell Rogers | gaynellrogers@gmail.com| 415.298.1114

Erica Glenn | ericaglenn.assistant@gmail.com| 530.912.2751


AxisWireAxisWireMay 31, 2019
img_kelsie.jpg

5min720

BOULDER, CO – May 31, 2019 /AxisWire/ KelSie Biotech, announced today that it has closed the first tranche of $5 million in Series A funding. The investment round, led by Salveo Capital, a leading cannabis focused investment firm, with participation from LA-based Arcadian Capital and other investors, will support the company’s scientific research and market expansion.

KelSie Biotech creates high bioavailability delivery methods for active pharmaceutical ingredients in the medical, nutraceutical and CBD/cannabis fields. KelSie licenses its patented and proprietary technologies which are based on novel particle morphology science and include dry-inhaled powder and true sublingual delivery systems. The dry-inhaled powder technology successfully completed Phase I Clinical Trials for delivery of a stable measles vaccine.

“KelSie is delighted to partner with Salveo and our other investors to bring effective and convenient drug and supplement delivery methods to more consumers,” said Cameron Keluche, KelSie Co-Founder. “We are committed to revolutionizing the delivery of cannabinoids and other drugs with superior bioavailability. Having experienced partners like Salveo and Arcadian is invaluable.”

“We constantly look for new and innovative technology that drives consumption patterns and introduces healthier and more discreet form factors across the pharma industry,” said Jeffrey Howard, a Managing Partner at Salveo Capital.  “We are impressed with KelSie’s strong patented and proprietary technology, including their true sublingual delivery systems with quick onset times. The Company’s focus on micro-dosing is another key differentiator that will continue to attract new demographics of cannabis/CBD consumers focused on low-dose health and wellness. We couldn’t be more excited to be working with the entire KelSie team to continue the company’s strong momentum.”

Historically, the most common method for administering medications and supplements has been oral or injection. But the gastrointestinal tract degrades the efficacy of pills and liquids before they reach the bloodstream and there are many complications to syringe-based methods.  KelSie’s patented breakthrough delivery methods revolutionize drug delivery for a wide range of applications.

Most recently, the technology has been successfully commercialized under the SUM Microdosebrand, licensed to State Operators producing fast-acting, water-soluble CBD/cannabis sublingual tablets. As SUM Microdoseapproaches its first successful year of sales in Colorado, the roll-out has begun across other states through licensing to additional State Operating Partners.

“Our consumer brand strategy is focused on investing in companies that truly add value to the consumption experience and have a high degree of commercial scalability. We believe that the KelSie’s core technologies provide a framework for the mainstream adoption of cannabinoid-based medicines,” said Krishnan Varier, Managing Partner of Arcadian Capital Management.

About KelSie Biotech

KelSie Biotech creates high bioavailability delivery methods for active pharmaceutical ingredients in the medical, nutraceutical and CBD/cannabis fields. The genesis of the technology came from Dr. Robert Sievers, who created an inhalable, needle-free measles vaccine that didn’t require refrigeration. Sievers received a $20 million, 5-year grant funded by the Bill and Melinda Gates Foundation to develop a measles vaccine that could be used effectively in rural regions lacking medical infrastructure. The first brand to deploy KelSie’s technology is SUM Microdose, water-soluble sublingual CBD/cannabis tablets.

About Salveo Capital

Launched at the end of 2016, Salveo Capital is an alternative investment firm specializing in the legalized cannabis space, particularly ancillary businesses. Salveo Capital’s approach is to bring an institutional quality discipline to company vetting, investment structures and portfolio management. The Firm is committed to shaping the early-stage, yet rapidly growing, industry by providing funding and development to companies with the will and vision to be the future faces of legalized marijuana. As cannabis legalization spreads, Salveo Capital seeks to build long term sustainable companies and support innovative technologies, products and services to help address the unique requirements of the industry. The firm is based in Northbrook, Illinois, and with vertical industry executives and cannabis operating advisors across the country, including key markets of California and Colorado. For more information, please visit www.salveocapital.com.

 


AxisWireAxisWireMay 29, 2019
img_hcm.jpg

4min2130

Brands including Kiva Confections, PRØHBTD, Foria Wellness, Futurola USA and more will appear at the dedicated marketplace

New York – May 28, 2019 /AxisWire/ The Hemp & Cannabis Marketplace will make its debut at next month’s 2019 Licensing Expo and today curators announced the 12 consumer brands set to take cannabis further mainstream through licensing partnerships.

The exclusive marketplace will showcase the leading health and wellness brands spanning various categories of the hemp, CBD and cannabis space, including:

The trailblazing brands were curated by PRØHBTD, a global consumer goods and content company in the cannabis and hemp industry that creates and markets lifestyle and wellness brands.

“We are in the branded products phase of the hemp and CBD industry,” says Drake Sutton-Shearer, CEO of PRØHBTD. “Working alongside Licensing Expo, we can open up new revenue streams and brand category expansion through licensing. It’s exciting to have all of these brands in one place for mainstream brands, retailers and manufacturers to potentially partner with ”

The world’s largest and most influential licensing industry event, Licensing Expo, takes place June 4–6 at the Mandalay Bay Convention Center in Las Vegas, NV.

The Hemp & Cannabis Marketplace will be located at Booth A133.

About PRØHBTD  

PRØHBTD is ahybrid consumer goods and content company recognized as the exclusive global cannabis partner of Licensing Expo, Advertising Week, All Def Media, Postmedia, and Entrepreneur Magazine.The company is venture-backed with $20M+ in funding and has offices in Los Angeles, New York, Toronto and Vancouver.

With a mission to lead cannabis from the black market to the supermarket, PRØHBTD creates and markets lifestyle and wellness brands to global audiences, overturning the taboos and stereotypes of the status quo cannabis vernacular and continually pushing it toward the mainstream.

For more information visit www.prohbtdglobal.com.

 

Media Inquiries

Rosie Mattio

Mattio Communications

Rosie@mattio.com

917-583-6349


AxisWireAxisWireMay 22, 2019
gmr.jpg

5min930

Cannabis Stocks Opened on a High Note First Quarter With 40% Index Growth

New York City – May 22, 2018 /AxisWire/ The Green Market Report (GMR), the cannabis industry’s most trusted source for credible in-depth financial and economic reporting, today released its 2019 Cannabis Company Index Q1 Summary Report. The report can be downloaded at GreenMarketReport.com/Reports.

The GMR Index follows the trading activity of 30 selected public cannabis companies that denote market dominance. The Company Index started 2019 on a high note as the first quarter jumped 40% and essentially recovering from the dismal fourth quarter of 2018. The broader stock market sold off at the end of the year and it took cannabis stocks along for the ride into the red territory. While the Farm Bill passage in December set the stage for stocks in the first quarter, Congress wasn’t through waving a green flag for the cannabis industry. . At the end of March, The House Financial Services Committee voted 45 to 15 to advance the Secure and Fair Enforcement (SAFE) Banking Act.

Despite all the positive news flowing through the cannabis industry, high profile lawsuits also reminded investors that the cannabis industry isn’t as mature as others. International markets are opening up to import and export. And U.S. exchanges are playing with Canadian companies while avoiding American ones.

“2019 is off to a good start for cannabis companies. Many stock valuations have recovered from the late 2018 selloff as the government seemed to soften its approach towards cannabis ,” stated Debra Borchardt, CEO of Green Market Report.

The best performing stock in the GMR Index was Origin House followed by The Green Organic Dutchman, who was the biggest loser last quarter. The biggest loser in the GMR Index was AeroGrow International.

The Index decided to add SLANG Worldwide Inc. and TILT Holdings Inc. While the Index was sad to let AeroGrow go, although it is the smallest of the publicly traded companies, as well as MedMen amid all of their legal woes.

“SLANG Worldwide has so many positives going for it. This was an easy name to add to the Index,” added Borchardt. “TILT Holdings though surprised the market with a large write down shortly after being added to the Index. We’ll monitor the stock closely.  .”

About Green Market Report:

The Green Market Report (GMR) is headquartered in New York City with an office in Los Angeles. GMR is poised to be the center for trustworthy business, financial and economic news and intelligence. The site offers coverage on financial matters including news briefs on business, cultivation, and extraction, cannabis company stock prices, and wholesale cannabis pricing. For more information, please visit www.greenmarketreport.com or email info@greenmarketreport.com. Follow us on Facebook, Instagram and Twitter @GreenMarketRpt.

Communications Contact:

Cynthia Salarizadeh

Green Market Report

856-425-6160

cynthia@salarmediagroup.com

 


AxisWireAxisWireMay 21, 2019
cgc-open-graph-image.jpg

14min420

SMITHS FALLS, ON, May 21, 2019 /AxisWire/ Canopy Growth Corporation (“Canopy Growth” or the “Company”) (WEED.TO) (CGC) is pleased to announce the appointment of Mike Lee to its executive leadership team in the acting role of Chief Financial Officer (CFO), effective June 1, 2019. Mike’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company.

Mike brings a wealth of experience from the consumer goods & beverages industry, having worked for companies such as E. & J. Gallo Winery, PepsiCo, and recently Constellation Brands, where he served as Senior Vice President & CFO for their US$3BWine & Spirits Division. He worked closely with Constellation Brands’ executive leadership to transform their premium Wine & Spirits business, applying financial rigor along the way with a true sense of urgency that translated strategy into action.  Mike also led the business transformation agenda at Constellation Brands, focused on digital enablement and operating model design. Most recently, Mike has served in the role of Executive Vice President, Finance at Canopy Growth Corporation.

Mike’s experience across these mature, category-leading CPG companies along with his experience in business transformation will be an asset as Canopy Growth continues to scale at an exponential rate. Taking advantage of his established strengths in developing high-performance teams, delivering financial results, and his ability to translate strategy into execution will help the Company’s leadership chart a course for the future.

Tim Saunders, whose invaluable contributions to the Company’s direction, finance leadership, and culture will continue to serve the executive team and Board of Directors of Canopy Growth as a strategic advisor in areas of mergers and acquisitions, corporate financing, and business transformation.

“When I welcomed Tim four years ago, Canopy Growth had a market cap of $93 million, two partially licensed production sites in Ontario and a single acquisition under our belt. After more than 26 acquisitions, 8 financings worth over $6.2 billion, the sector’s first TSX and NYSE listings, and reaching a market cap of $21 billion, Tim exemplifies what it means to be a leader at Canopy Growth,” said Bruce Linton, Chairman and Co-CEO, Canopy Growth. “As Tim transitions roles, I am also pleased to elevate Mike into the acting CFO role. His philosophy, accomplishments and all-around track record give me confidence that the Company’s financial health and governance are in good hands. I look forward to working more closely with Mike, benefitting from his vision and expertise as the Company continues growing, both at home and abroad.”

The Board of Directors, co-CEOs Bruce Linton and Mark Zekulin, along with the whole Canopy Growth family, thank Tim Saunders for his dedication and leadership. Having championed the financial health of the Company through an aggressive phase of M&A growth, multiple financing rounds, and historic listings on the TSX and NYSE, both firsts for cannabis companies, Tim’s impact on Canopy Growth is permanent and sincerely appreciated.

Here’s to Future Growth (now with Mike!).

About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through the Company’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has operations in over a dozen countries across five continents.

The Company’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

The Company operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 4.4 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com

Notice Regarding Forward Looking Statements
This news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements include statements with respect to changes to the leadership team. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including the Company’s ability to satisfy provincial sales contracts or provinces purchasing all cannabis allocated to them, and such risks contained in the Company’s annual information form dated June 27, 2018 and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.


AxisWireAxisWireMay 21, 2019
img_leftcoast.jpg

6min600

SAN FRANCISCO–May 21, 2019 /AxisWire/ Today, three-time GRAMMY® winner and Grateful Dead drummer Mickey Hart announces the launch of Mind Your Head ™, an innovative cannabis brand produced in California in partnership with Left Coast Ventures™. Mind Your Head is inspired by the groundbreaking culture of creativity and community that Hart helped create and continues to foster through his art and his band, Dead & Company, which launches their summer tour on May 31 st at Shoreline.

The Mind Your Head brand’s first product offering is Magic Minis, pre-rolled whole-flower joints packaged in a tin adorned with Hart’s celebrated artwork. These collectible tins are available in select Bay Area dispensaries:

  • Urban Pharm (San Francisco)
  • Sparc (San Francisco)
  • Berkeley Patients Group (Berkeley)
  • Hi-Fidelity (Berkeley)
  • Airfield Supply Co. (San Jose)
  • Mercy Wellness (Cotati)

With the Mind Your Head cannabis brand, Hart is seeking to share an essential part of the inspiration behind his work as a musician and artist that created a cultural phenomenon with The Grateful Dead.

“Cannabis is about opening the mind by inspiring intellectual curiosity and breaking free from ordinary thinking,” Hart said. “Throughout my life, cannabis has played an important role in inspiring creativity and I hope that Mind Your Head cannabis activates others to find their own dimension of creativity. It’s about transporting your mind, connecting with the rhythm of your body and getting into the zone.”

Mind Your Head Magic Minis feature Chemdog, a legendary strain discovered outside a Grateful Dead show on Shakedown Street in 1991 by a loyal fan now known as ‘Chemdog.’ The namesake strain of cannabis is renowned for boosting artistry and mindfulness. True to Hart’s vision, the Chemdog strains produced for Magic Minis were mindfully grown, pursuing kindness and care in cultivation practices.

“As a loyal Deadhead, I’m proud to see Chemdog featured in the first product from Mickey Hart,” said Chemdog. “It plays an important role in Grateful Dead history and I think it’s exciting that Mickey is bringing it full circle to fans and cannabis enthusiasts in Mind Your Head.”

Left Coast Ventures is a diversified cannabis and hemp company working to shape the future of the legal cannabis industry in the United States — starting with California, the world’s largest legal cannabis market. Left Coast’s portfolio of brands has grown through acquisition, investment and incubation, covering the spectrum from cultivation to distribution and retail.

“We are proud to introduce California enthusiasts to a premium cannabis brand rooted in a global movement that spans generations,” said Left Coast Ventures CEO Brett Cummings. “It’s a true honor to work with a legendary musician and activist who has inspired millions of individuals and shares our values and passion to legitimize the future of cannabis.”

About Mind Your Head

Mind Your Head is a cannabis brand from legendary Grateful Dead drummer and visual artist, Mickey Hart. The brand is founded on the belief that cannabis grown with care can transport minds by inspiring creativity and mindfulness. Mind Your Head operates using sustainable, just and innovative practices. It is currently available in select Bay Area dispensaries, with plans to expand distribution in 2019. Learn more at mindyourheadcannabis.com.

About Left Coast Ventures

Headquartered in Santa Rosa, CA, Left Coast Ventures is a diversified cannabis and hemp company specializing in cultivation, manufacturing, brand development and distribution. Left Coast Ventures and its subsidiaries are working to shape the future of the legal cannabis industry in the United States through acquisitions, investments, and incubation while building a respected portfolio of top shelf brands. Wholly owned, licensed, and distributed brands in Left Coast Venture’s portfolio include: Marley Natural™, Mind Your Head™, Headlight™, Dutchy, and JEF™.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190521005355/en/

CONTACT: Ann Peltz, Media Relations

press@leftcoastventures.us


AxisWireAxisWireMay 14, 2019
img_navgen2.jpg

5min1240

Top MMJ Influencers sign Affiliate Education Agreements with Navigator Genomics™ Testing

New Orleans, Louisiana – May 7, 2019 /AxisWire/ Navigator Genomics™ (NGT) has signed 3 new Affiliate Agreements to collaborate with Dr. Michele Ross CEO of Infused Health, Dr. Lakisha Jenkins (Jamaica), and Donna Shields, MS, RDN to provide NGT’s educational content services for their clients.

Navigator Affiliates receive news articles, links to NGT’s fully vetted cannabis glossaries, videos, webinars, science whitepapers, & chronic medical condition information focused on the very same conditions consumers must have to qualify for medical cannabis…. all content is at No Cost to affiliates.

Dr. Michele Ross – CEO of Infused Health

Dr. Michele Ross is a neuroscientist who first published on the endocannabinoid system in 2006 and  went from academia to cannabis health coaching after cannabis helped her recover from several chronic health issues including fibromyalgia. Infused Health is an online cannabis coaching network supporting clients who need more information about cannabis treatment than their doctors or budtenders can provide. She focuses on helping women & adult patients with chronic pain, anxiety, and depression live healthier & happier lives by using the right cannabis products.

Dr. Ross states “Navigator Genomics is the perfect tool for determining whether or not it is safe for a patient to take cannabis products containing THC or CBD with their current medications. Most of our Infused Health clients are on more than one medication, and this genetic test helps prevent dangerous drug-drug interactions.” https://infusedhealth.com/about-us

Dr Lakisha Jenkins-(Jamaica)Dr. Jenkins is a Cannabis Practitioner, Naturopath, Registered Master Herbalist and teacher of the endogenous cannabinoid system.

Dr. Jenkins involvement in medical cannabis began in 2006. She was a Founding Board Member & first elected President of the California Cannabis Industry Association in 2012 , the National Cannabis Industry Association Board (2013-2015) & the founding Chair of their Minority Business Council. Dr Jenkins works to ensure all people have the right to choose their best treatment options. https://www.drlakisha.com

Donna Shields, MS, RDN is co-founder of the Holistic Cannabis Academy, an online education training program using an integrative medicine approach. Her diverse career spans the US Army Medical Corp, global health communications for The Coca-Cola Company & faculty at the Culinary Institute of America. Based in Colorado and Florida, she’s been a contributor to The Cannabis Kitchen Cookbook and consults  for the cannabis and hemp industries. https://donnashields.net

Navigator Genomics™

NGT is the first pharmacogenomics company to measure & report your personal genetic responses to key cannabinoids utilized in Medical Cannabis (MMJ), simultaneously with416 of the most popularly prescribed prescription medications (Rx) taken by the most amount of people. Results include important potential drug-drug interactions which can reduce or cancel efficacy of MMJ or Rx’s, create unwanted side-effects or even adverse reactions. Consumers can avoid costs & time of traditional “trial and error” dosing. Results help personalize which cannabinoids & medications can work best for each person. NGT’s lab is CLIA & CAP accredited to ensure highest quality standards. All information is private and HIPAA compliant. Tests are $299 sold direct-to-consumer on line at: https://navigatorgenomics.com.

*Navigator is actively seeking affiliates to collaborate with medical cannabis digital publications, educators, cannabis doctor organizations, researchers, MMJ science studies, product manufacturers, dispensaries, and analytic data firms. Navigator provides free educational content, videos, webinars, news articles, etc. to affiliates who desire to educate their constituents.

Media Contact:

Ivan Echegarrua
info@navigatorgenomics.com
Toll Free: (877) 892-2324

Navigator Genomics™
314 Southern Rd.
River Ridge, Louisiana 70123


AxisWireAxisWireMay 14, 2019
img_mjlink.jpg

6min260

NEW YORK, May 14, 2019 /AxisWire/ via CannabisNewsWire — MjMicro Conference (www.mjmicro.com), the next-level investor forum for publicly traded cannabis companies, debuts in New York City on June 25 at the Westin Grand Central Hotel. This one- day conference provides an exceptional opportunity for cannabis-related public entities to connect with private capital investors and also features presentations from noted industry experts.

The MjMicro Conference is an invitational networking forum exclusively created to enable best- in-class and emerging public companies in the cannabis industry to meet with high-net-worth investors, venture funds and family offices, helping drive private investment capital into public entities, promote trading liquidity, and increase media and analyst coverage.

“Our goal is to provide both the most exciting and diverse range of public company investment opportunities, ranging from micro to mid-cap companies that have proof of concept, revenue streams, audited financials and public market liquidity,” noted George Jage, president of MjLink.com and producer of MjMicro. “This event creates direct C-suite access for investors to provide insight into their vision, strategy and performance.”

Confirmed presenting companies include 1933 Industries, CannAmerica Brands, Cannex Capital Holdings, Cardiol Therapeutics, Dixie Brands, Emerald Health Therapeutics, FSD Pharma, Helix TCS Inc., High Tide Inc., House of Jane, Province Brands of Canada, MJ Freeway, Tauriga Sciences, United Cannabis Corp., and Vireo Health.

“FSD Pharma, a spotlight presenter, is endemic of the exciting opportunities in the market. They are a Canadian licensed producer developing cutting-edge technology and conducting research related to the treatment of chronic pain, fibromyalgia and other medical conditions that are typically treated with pharmacological applications,” noted Todd Markey, director of investor relations at MjMicro.

“There are over 400 cannabis-related public companies in the market today, and we project that anywhere between 100 and 200 others will get listed in the next 24 months,” stated Jage. “There has been a race for cannabis companies to access the public capital markets, but the industry lacks the access to institutional capital that you would expect in such a fast-growth industry. This event provides the solution on both sides of the table.”

MjMicro is scheduled to be held four times a year with events in New York, Beverly Hills, West Palm Beach and Seattle. MjMicro is produced by MjLink.com Inc., which is a wholly owned subsidiary of Social Life Networks (OTC: WDLF).

To learn more about MjMicro Conference or to request an invitation to attend, sponsor or present, please visit https://www.mjmicro.com.

About MjLink.com Inc.

Social Life Network (OTC: WDLF), a cloud-based social media and social network technology company based in Denver, Colorado, announced on Sept. 25, 2018, that the Company had spun its cannabis technology division out of the parent company and incorporated MjLink.com Inc., a Delaware Corporation, as its wholly owned subsidiary. MjLink operates as a multinational cannabis technology and media organization with two separate social networks: WeedLife.com, a consumer-to-consumer network; and MjLink.com, a business-to-business social network. On April 4, 2019, the president of MjLink, George Jage, announced the launch of a new division of the Company that is focused on providing the industry with best-in-class financial, B2B and B2C cannabis-centric events that complement the Company’s global social networks.

For more information about Social Life Network and to download the MjLink Investor Deck, visit https://social-life-network.com

Disclaimer

This news release may include forward-looking statements within the meaning of section 27A of the United States Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, with respect to achieving corporate objectives, developing additional project interests, the company’s analysis of opportunities in the acquisition and development of various project interests and certain other matters. No information in this press release should be construed as any indication whatsoever of the Company’s or MjLink’s future financial results, revenues or stock price. There are no assurances that the Company will successfully take MjLink.com, Inc public. These statements are made under the “Safe Harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein. The relationship between Social Life Network and the other companies mentioned currently does not extend beyond inviting them to send representatives to speak at the MjMicro Conference.

Contact:

Investor Relations: IR@Social-Life-Network.com 855-933-3277

 


AxisWireAxisWireMay 7, 2019
img_hawaii2.jpg

8min2930

Arcadia Biosciences’ Hawaiian Hemp Farm in Full Bloom

Arcadia Specialty Genomics, the company’s new cannabis unit, cultivates six Hawaiian hemp strains on its 10-acre Hawaiian facility.

DAVIS, Calif. (May 7, 2019) /AxisWire/ – Just two months after announcing the launch of Arcadia Specialty Genomics™, a new cannabis-dedicated division of agricultural crop improvement leader Arcadia Biosciences, the company is releasing images of its first crop of sun-grown, Hawaiian hemp.

Arcadia Specialty Genomics focuses on the development of novel cannabis varieties possessing productivity, pest resistance and crop quality traits for license to cultivators in federal and state legal markets, and as products such as hemp-derived CBD oils for the nutraceutical and food industries.

In March, the company revealed it had been granted an Industrial Hemp Pilot Program (“HIHPP”) License by Hawaii’s Department of Agriculture. The license allows for the cultivation of industrial hemp for the purposes of agricultural and academic research. Hemp and hemp products produced under the program may be commercially sold.

With a 10-acre field station in Hawaii, Arcadia is producing its first research crop of hemp to test the impact of climate and geography on crop parameters like yield and quality. Arcadia Specialty Genomics’ scientists and agronomists are evaluating and characterizing the performance of a number of local strains against various climate and biological conditions to understand the attributes of each, as well as identify opportunities for improvement. In addition, the company has hired full time staff at its Hawaii facility to oversee the ongoing research and grow operations.

“It’s highly gratifying to see our first hemp research crop taking root in Hawaii, having planted six different Hawaiian strains,” said Matt Plavan, president of Arcadia Specialty Genomics and CFO of Arcadia Biosciences. “In order to solve for crop variability – a major concern for U.S. hemp farmers – we first need to understand its drivers. We’re applying the sound, scientific approaches we’ve used to improve other crops, such as wheat, to create new breeds of superior hemp.”

Hawaii is the first state where Arcadia Specialty Genomics has commenced its research and cultivation of hemp in federal and state legal cannabis markets, using non-GMO techniques to produce superior U.S. hemp crops.

While traditional agricultural crops can be difficult to grow and export economically in Hawaii, the rich soil and warm climate are ideal for cultivating high-value crops such as hemp.

Arcadia Biosciences is a recognized leader bringing deep experience and established capabilities in this kind of crop innovation and optimization, delivering proven results safflower, wheat and durum such as:

  • A 100 percent increase in the production of omega-6 GLA for safflower
  • Two to six times more fiber than standard wheat and durum with its proprietary GoodWheat™ flour
  • A 65 percent reduction in allergenic gluten content in its GoodWheat™ flour
  • 30 percent more lysine, an essential amino acid, in GoodWheat™ compared to standard wheat

The company expects to harvest its first crop of Hawaiian-grown research hemp this summer. For more information, visit www.arcadiabio.com.

About Arcadia Specialty Genomics

Arcadia Specialty Genomics is a strategic business unit of Arcadia Biosciences, Inc. leveraging the market-leading capabilities of its parent company to deliver crop innovation into developing proprietary, industry-leading cannabis germplasm. Focused on productivity, pest resistance and favored quality traits, Arcadia Specialty Genomics’ innovations serve the state- and federally-legal nutraceutical, food and industrial markets. For more information, visit www.arcadiaspecialtygenomics.com

About Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. (Nasdaq: RKDA) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. Arcadia’s GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. The company’s agricultural traits are being developed to enable farmers around the world to be more productive and minimize the environmental impact of agriculture. For more information, visit www.arcadiabio.com.

Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: Arcadia Specialty Genomics’ expectations about the cannabis industry and potential demand for our products; the uncertainty of the laws and regulations relating to cannabis and products derived therefrom; the inherent uncertainty associated with the development of new projects; our ability to obtain proper licenses and successfully complete research programs related to cannabis; the acceptance of our products in the marketplace; the impact of competitive products and pricing;  risks related to costs, delays and uncertainties associated with potential future scientific research, product development, clinical trials and the regulatory approval process; our partners’ and affiliates’ ability to develop commercial products incorporating cannabis related traits, and complete the regulatory review process for such products; our compliance with laws and regulations that impact our business, and changes to such laws and regulations; our future capital requirements and ability to satisfy our capital needs; our ability to develop, enforce and defend our intellectual property rights; and the other risks set forth in our filings with the Securities and Exchange Commission from time to time, including the risks set forth in our Annual Report on Form 10-K for the year ended December 31, 2018 and other filings. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. disclaims any obligation to update these forward-looking statements.

Twitter: @ArcadiaAg on Twitter
LinkedIn: Arcadia Biosciences

Press Contacts:

Trailblaze PR
Lisa Weser
lisa@trailblazepr.com



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 6 hours

Executive Spotlight: Ben Kovler, CEO, Founder & Chairman of Green Thumb Industries (GTI)

Back to Top

You have Successfully Subscribed!